PAS-22-197 - Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research |
NOT-CA-24-031 |
NCI , NHLBI , NIA , NIDA , NIMH , NINR , OBSSR , ODSS
|
Feb 15, 2024 |
Jul 6, 2025
|
R61/R33, R01, R21, R43/R44, R34, R41/R42 |
Notice of Special Interest: Development of Radiotracers for Diagnosis and Clinical Studies in Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) |
NOT-AG-22-032 |
NIA
|
Sep 28, 2022 |
Sep 5, 2025
|
R43/R44, R41/R42, R01, U01, R21 |
Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health |
NOT-OD-21-100 |
OBSSR , NIMHD , NIDA , NIMH , ORWH , NIDCD , SGMRO , ODP , NIA , NHLBI , NCI , NINR , NCCIH , NEI , NICHD
|
Apr 8, 2021 |
Jun 8, 2024
|
R01, R21, R03, R41/R42, R43/R44, R21/R33, UG3/UH3, R34 |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Correction to the Application Types Allowed Information for PAS-22-197, Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) |
NOT-AG-22-029 |
NIA
|
Aug 26, 2022 |
n/a
|
R41/R42 |
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research |
NOT-CA-22-037 |
NCI NHLBI NIA NIDA NIMH NINR OBSSR
|
Jan 27, 2022 |
Mar 9, 2024
|
R01, R03, R21, R43/R44, R41/R42, R33, R34, R61/R33 |
|